Zhongke Borui Completes Tens of Millions of RMB Series B Financing to Advance Full-Chain Brain-Computer Interface Strategy

Recently, Casibrain (Beijing) Technology Co., Ltd. ("Casibrain Technology"), a high-end medical device company incubated by the Institute of Automation, Chinese Academy of Sciences, officially announced the completion of a multi-million yuan Series B round of financing. This round of financing was invested by Sanze Venture Capital, with WinX Capital serving as the long-term exclusive financial advisor. This capital injection will fully support Casibrain Technology in deepening its industrial chain layout for brain-computer interfaces.

Casibrain Technology, founded in 2017, always adheres to the R&D concept of "brain-centered" and the corporate mission of "refining brain diagnosis skills and shouldering the important task of brain protection," focusing on the medical device transformation and industrialization of brain-computer interface technology.